Sistema sold Obolenskoe to Russian Direct Investment Fund and the Russian-Chinese Investment Fund.

Synopsis

Sistema sold a minority stake in Obolenskoe, a Russia-based pharmaceutical company, to Russian Direct Investment Fund and the Russian-Chinese Investment Fund. Financial terms were not disclosed.

Principals

target

OBOLENSKOE

bidder

Russian Direct Investment Fund

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

latham & watkins

HQ - New York, United States

legal advisors

vendor

5558

Deals

£ 3,639.15 B

Total Value